Glaucoma Trial, Recruiting

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• People who are willing and able to give informed consent to take part
• People who have been clinically diagnosed with primary open angle glaucoma (a common type of glaucoma where the eye's drainage angle is open), including a type called normal tension glaucoma
• People who have been clinically diagnosed with ocular hypertension (higher than normal pressure inside the eye, without glaucoma damage)
• People whose eye drainage angles are confirmed as open on a specialist eye examination
• People aged 18 or older, of any gender
• People whose cornea (the clear front surface of the eye) measurements fall within a specific size range in the eye being studied (confirm with trial site)
• People whose corneal thickness in the study eye falls within a specific range — between 490 and 600 micrometres (confirm with trial site)

Who may not be able to join:

• People who have any eye condition other than glaucoma or ocular hypertension
• People who have previously had surgery or laser treatment for glaucoma, cataracts, or vision correction
• People who have an abnormality of the cornea or the white of the eye that would prevent wearing a contact lens
• People who have insufficient tear production (dry eye affecting the ability to wear contact lenses)
• People who have a known allergy to eye numbing drops (corneal anaesthetic)
• People who have a medical reason they cannot wear silicone contact lenses
• People who have a medical reason they cannot take the study medications — Diamox, Latanoprost, or Timolol (confirm with trial site)
• People who have skin irritation, eczema, or another condition that prevents wearing adhesive patches on the skin
• People who are unable or unwilling to follow the study procedures
• People who do not have the capacity to give informed consent
• People with a history of heart failure, a treated heart condition, or kidney failure
• People with known cognitive (thinking or memory) disorders
• People who are unable to follow study procedures for any reason, such as language difficulties, psychological conditions, or dementia
• People who are currently taking part in, or have taken part in, another clinical trial involving an experimental drug within the past 30 days
• The trial investigators themselves, their family members, employees, or anyone else in a dependent relationship with the investigator

Important: Always verify eligibility with the trial site directly before applying.